Avience Biomedicals Ltd. IPO
IPO Timeline
-
18 Jun 2026Bidding Starts
-
22 Jun 2026Bidding Ends
-
23 Jun 2026Allotment Finalization
-
25 Jun 2026Listing
About Avience Biomedicals Ltd.
Our Company was originally incorporated as Private Limited, under the Companies Act, 2013 (“Companies Act”) in the name and style of “Avience Biomedicals Private Limited” on December 23, 2019, under the provisions of the Companies Act, 2013 vide Certificate of Incorporation issued by the Registrar of Companies, Delhi. Later, company was converted into a public limited company, the name of our Company was changed to “Avience Biomedicals Limited” and fresh Certificate of Incorporation dated September 03 rd, 2024, was issued by the Registrar of Companies, Delhi.
Recognized under the Make in India Mission initiated by Prime Minister Narendra Modi, The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, HIV, HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good quality solutions.
Avience Biomedicals has expanded its product range from IVD rapid test kits to include a comprehensive line of medical devices such as Serology products, Biochemistry Analyser and Biochemistry Reagents, showcasing a dedication to addressing various healthcare needs.
Avience Biomedicals Ltd. IPO Reservation
| Investors Category | Shares Offered |
|---|---|
| Anchor Investors | 4,09,800 (28.19%) |
| Market Makers | 82,200 (5.65%) |
| Non Institutional Investors | 2,07,000 (14.24%) |
| Qualified Institutional Buyers (QIBs) | 2,73,600 (18.82%) |
| Retail Individual Investors (RIIs) | 4,81,200 (33.1%) |
Avience Biomedicals Ltd. Financial Information
| Year End | Revenue | PAT | Reserves & Surplus |
|---|---|---|---|
| 31 Mar 2025 | 29.54 Cr | 5.14 Cr | 16.49 Cr |
| 31 Mar 2024 | 16.64 Cr | 1.98 Cr | 2.77 Cr |
| 31 Mar 2023 | 10.93 Cr | 70.78 Lakh | 78.52 Lakh |
Avience Biomedicals Ltd. Background
-
2022Inauguration of Noida Factory
A new production facility was established in Noida during the pandemic to support the country in its fight against COVID-19.
Initiated E-Commerce Sales through Government e-Marketplace (GeM) OEM
We were certified as an OEM in GeM and started our e-commerce operations as a result.
New Manufacturing Licenses
In FY 2022-23, we received approval for 10 additional production licenses
-
2023Tenfold increase in turnover during FY 2021-22
We achieved an approximately tenfold growth in turnover in FY 2021-22. In FY 2020-21, the turnover was ?113.30 lakhs, which increased to ?1,014.75 lakhs year over year.
New Manufacturing Licenses
We obtained four manufacturing licenses in FY 2021-22 which are as follows:
1. Viral Transport Pack
2. Pregnancy Card Pregnancy
3. Strips Covid 19
4. RT PCR Assay
Allotment of land
We secured an allotment of commercial land measuring 2,100 square meters within the Medical Device Park, located in the Yamuna Expressway Industrial Development Area, at a nominal lease rate. This strategically positioned land offers excellent connectivity to the airport and the expressway, enhancing logistical advantages for operations.
First Export Consignment Dispatched
The first export order has been successfully dispatched in FY 2023-24.
Export Entry into the African Continent – Somalia
The first export order to Somalia has been successfully completed and Company has entered the African continent.
International Export Registration – Ethiopia
We received approval from the Ethiopian Food and Drug Authority (EFDA) to export our products.
Winning a bid in Andhra Pradesh for ₹82.05 lakhs
We received a large government supply order after winning a bid in Andhra Pradesh for ?82.05/- lakhs.
WHO Good Manufacturing Practice GMP Approval
The WHO recognized our manufacturing process as a Good Manufacturing Practice (GMP) for producing quality products that meet international quality standards.
MSME ZED Gold Certification
As of November 13, 2024, there are only 1515 Zed Gold holders in India, and our company is one of them.
New Manufacturing Licenses
In FY 2023-24, we received approval for 31 new production licenses
-
2024Laying of the foundation stone for the new factory
Laying the foundation stone for the new large production facility at the Medical Device Park at Yamuna Expressway Industrial Development Area.
Sickle Cell Approval
We are one of the few manufacturers in India to receive validation for the sickle cell test from ICMR.
Received the first license for the hematology analyzer
We obtained our first license for manufacturing hematology equipment in FY 2024-25.
Conversion of company
Transitioned to a public company, marking a significant milestone in our growth and expansion.
New Manufacturing Licenses
In FY 2024-25, we received approval for 32 new production licenses
-
2025New Manufacturing Licenses
In FY 2025-26, we received approval for 11 new production licenses
-
2026New Manufacturing Licenses
In FY 2025-26, we received approval for 10 new production licenses
1. Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
2. Funding the working capital requirement of our Company
3. General Corporate Purpose
| Pricing Details | BSE | NSE |
|---|---|---|
| Issue Price | - | ₹ 208.00 |
| Open | - | ₹ 395.20 |
| Low | - | ₹ 395.20 |
| High | - | ₹ 414.95 |
| Last Trade | - | ₹ 414.95 |
1. Mr. Dharam Deo Choudhary
2. Mr. Ram Nagina Choudhary
3. Mr. Janardan Pal
4. Mrs. Deepa Choudhary
The Indian Pharmaceuticals industry plays a prominent role in the global pharmaceuticals industry. Major segments of Indian Pharmaceutical Industry include diagnostic kits, medical devices etc.
The healthcare and medical device sectors in India have grown significantly in the last decade. ... Read more
Phone no:18001204636
FAQs
When does Avience Biomedicals Ltd. IPO opens and closes?
Avience Biomedicals Ltd. IPO opens from 18th June to 22nd June 2026.What is the size of Avience Biomedicals Ltd. IPO?
The size of the Avience Biomedicals Ltd. IPO is ₹30.24 Cr.What is the price range of Avience Biomedicals Ltd. IPO?
The price range of Avience Biomedicals Ltd. IPO is at ₹196 to ₹208 per share.What is the minimum investment and lot size required for the Avience Biomedicals Ltd. IPO?
The minimum investment required is ₹1,24,800 and minimum lot size is 600 shares.When is Avience Biomedicals Ltd. IPO listing date?
The Avience Biomedicals Ltd. IPO will be listed on 25th June 2026.What is the objective of Avience Biomedicals Ltd. IPO?
1. Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh2. Funding the working capital requirement of our Company
3. General Corporate Purpose
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article


Click it and Unblock the Notifications